View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Cedric Rossi
  • Cedric Rossi

Fielmann: Reassuring start to the year

With Q1 sales and EBITDA both up 11% YoY, FIE has reassured the market despite a demanding comparison base and challenging macro environment, particularly in Germany. Similarly, FY24 sales outlook highlights robust top-line trends through the year, whilst FIE's prudent EBITDA target leaves some ups

Clement Genelot
  • Clement Genelot

Food Retail: Leclerc's insolent outperf fuels risk of competitive irra...

Latest Kantar French market share data highlight a continued and surprising outperformance by Leclerc (+80bp) despite very tough comps vs. other independents and Lidl (slightly up) and vs. integrated groups (down 100bp). The wide gap between Leclerc and Intermarché, Systeme U and Lidl in a fast-dec

Cleveland-Cliffs Inc: 2 directors

Two Directors at Cleveland-Cliffs Inc bought 85,000 shares at between 16.761USD and 16.995USD. The significance rating of the trade was 84/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors ov...

ABGSC Healthcare Research ... (+2)
  • ABGSC Healthcare Research
  • Morten Larsen
Florent Laroche-Joubert
  • Florent Laroche-Joubert

Altarea : A strong performance from retail and progress on the road ma...

>A strong operating performance from the three business lines - Altarea reported a performance for Q1 2024 (revenues € 578.9m, +4% y-o-y) which reflects above all an outperformance from retail but also the end of the clearing of the housing supply from the previous cycle while business property is making progress.Retail (revenues € 67.3m, +11.8% y-o-y): all indicators are showing a very positive trend and above peers with: 1/ retailer sales at +7% y-o-y for foot...

Benoit Valleaux ... (+2)
  • Benoit Valleaux
  • Steven Gould

BBVA : Potential M&A deal with Banco Sabadell – initial assessment

>The underlying strategic rationale is still there… - In a surprise move, BBVA announced its concrete/formal interest in Banco Sabadell the day after reporting its Q1 2024 results and probably following a leak in the media. It is still too early, in the absence of details around the terms, to properly evaluate the relevance of the move (we clearly maintain our positive stance on the stock and our target price at this stage), although we can already provide an initial ...

Nicolas David
  • Nicolas David

Capgemini : CA T1 2024 satisfaisant. FY 24 guidance réitérée mais le h...

>Croissance à cc en ligne avec les attentes. Bookings solides - Capgemini a annoncé mardi avant Bourse un CA T1 2024 satisfaisant, avec une variation cc de -3.3%, +20 pb au-dessus des attentes. L’Amérique du Nord continue à être pénalisée par un mix moins favorable (-7.1% cc) alors que l’Europe continue à faire preuve d'une plus grande résilience, enregistrant un léger ralentissement de la croissance, comme prévu (-1.8% cc). Les secteurs TMT et services financiers so...

 PRESS RELEASE

Shell announces commencement of a share buyback programme

Shell announces commencement of a share buyback programme Shell plc Shell announces commencement of a share buyback programme May 2, 2024 Shell plc (the ‘Company’) today announces the commencement of a $3.5 billion share buyback programme covering an aggregate contract term of approximately three months (the ‘programme’). The purpose of the programme is to reduce the issued share capital of the Company. All shares repurchased as part of the programme will be cancelled. It is intended that, subject to market conditions, the programme will be completed prior to the Company’s Q2 20...

 PRESS RELEASE

EQS-News: PANCREACTIC CANCER: SUCCESFUL TRIAL AGAINST PANCREATIC CANCE...

EQS-News: Defence Therapeutics Inc. / Key word(s): Miscellaneous PANCREACTIC CANCER: SUCCESFUL TRIAL AGAINST PANCREATIC CANCER WITH DEFENCE’S ARM-002 ANTI-CANCER VACCINE 02.05.2024 / 08:00 CET/CEST The issuer is solely responsible for the content of this announcement.   _________________________________________________________________ CSE: DTC  FSE: DTC  USOTC: DTCFF       PRESS RELEASE   PANCREACTIC CANCER: SUCCESFUL TRIAL AGAINST PANCREATIC CANCER WITH DEFENCE’S ARM-002 ANTI-CANCER VACCINE   Vancouver, BC, Canada, May 1st, 2024 - Defence Therapeutics Inc. (“Defenc...

 PRESS RELEASE

Block Listing Six Monthly Return

Gulf Keystone Petroleum Ltd (GKP) Block Listing Six Monthly Return 02-May-2024 / 07:00 GMT/BST   2 May 2024     Gulf Keystone Petroleum Ltd. (LSE: GKP) (“Gulf Keystone”, “GKP” or “the Company”)   Block Listing Six Monthly Return   (Note: Italicised terms have the same meaning as given in the Listing Rules.)   Name of applicant: Gulf Keystone Petroleum Limited Name of scheme: Deferred Bonus Plan/Long Term Incentive Plan Period of return: From: 3 November 2023 To: 2 May 2024 ...

 PRESS RELEASE

Cairn Homes Plc: Transaction in Own Shares

Cairn Homes Plc (CRN) Cairn Homes Plc: Transaction in Own Shares 02-May-2024 / 07:00 GMT/BST 02 May 2024   Cairn Homes plc (the “Company”) Transaction in own shares     The Company announces that on 1st of May 2024 it purchased a total of 43,299 of its ordinary shares of EUR 0.001 each (the "ordinary shares") on Euronext Dublin and the London Stock Exchange through the Company's broker Goodbody Stockbrokers UC (“Goodbody”), as detailed below. The repurchased shares will be cancelled.     Euronext Dublin London Stock Exchange Number of ord...

 PRESS RELEASE

Interim report for the first quarter of 2024 – Operating profit in lin...

Ørsted A/S (Orsted) Interim report for the first quarter of 2024 – Operating profit in line with expectations, with offshore site earnings increasing 18 %. Business plan progressing with Sunrise Wind award and completion of two offshore wind farms 02-May-2024 / 07:59 CET/CEST 2.5.2024 07:59:37 CEST | Ørsted A/S | Interim report (Q1 and Q3) Today, Ørsted’s Board of Directors approved the interim report for the first quarter of 2024. Mads Nipper, Group President and CEO of Ørsted, says in a comment to the interim report for the first quarter of 2024:“We are working diligently on ex...

 PRESS RELEASE

Shell plc First Quarter 2024 Interim Dividend

Shell plc First Quarter 2024 Interim Dividend London, May 2, 2024 − The Board of Shell plc (the “Company”) today announced an interim dividend in respect of the first quarter of 2024 of US$ 0.344 per ordinary share. Details relating to the first quarter 2024 interim dividend Per ordinary share Q1 2024 Shell Shares (US$) 0.344 Shareholders will be able to elect to receive their dividends in US dollars, euros or pounds sterling. Absent any valid election to the contrary, persons holding their ordinary shares through Euroclear Nederland will receive their ...

 PRESS RELEASE

Shell plc publishes first quarter 2024 press release

Shell plc publishes first quarter 2024 press release  London, May 2, 2024                                                                                                     "Shell delivered another quarter of strong operational and financial performance, demonstrating our continued focus on delivering more value with less emissions. We continue to deliver on our Capital Markets Day targets, giving us the confidence to commence another $3.5 billion buyback programme for the next three months."  Shell plc Chief Executive Officer, Wael Sawan     DELIVERING STRONG Q1 RESULTS Q1 2024 Ad...

ABGSC Healthcare Research ... (+2)
  • ABGSC Healthcare Research
  • Morten Larsen

Impressive cash flow

Q1e: -2% revenue growth on FX hit, Strategic brands keeps growing. Vyepti and Rexulti cases gaining more momentum in Q1. The pipeline-rebuilding story has gained traction recently.

Louis Boujard ... (+3)
  • Louis Boujard
  • CFA
  • Philippe Ourpatian

Fortum : Une bonne publication mais peu de perspectives

>Un résultat supérieur aux attentes - L'EBITDA comparable s'est élevé à 622 M€ (-20 %YoY), au-dessus de nos attentes de 525 M€ et du consensus Vara de 549 M€. L’EBIT comparable s'élève à 530 M€ (-24%) au-dessus de notre prévision et du consensus à 452 M€. Le résultat net a également été meilleur qu'attendu à 430 M€ (-11%) contre 350 M€ attendus (ODDO BHF et consensus). Par division la surprise vient de l’activité génération électrique avec un EBIT de 513 M€ (-29%) con...

Florent Laroche-Joubert
  • Florent Laroche-Joubert

Altarea : Belle performance du commerce et des avancées sur la feuille...

>Bonne performance opérationnelle sur les 3 lignes de métier - Altarea publie une performance sur le T1 2024 (CA à 578.9 M€ ; +4% yoy) qui traduit surtout une surperformance du commerce mais également la fin de l’écoulement de l’offre de logements issue du précédent cycle tandis que l’immobilier d’entreprise connait des avancées :Commerce (CA 67.3 M€ ; +11.8% yoy) : tous les indicateurs sont très bien orientés et au-dessus de ses pairs avec 1/ un CA commerçants à...

Ana Arjona-Martinez ... (+2)
  • Ana Arjona-Martinez
  • Yan Derocles

AENA : Good start of the year and confident tone for the rest of 2024

>Solid Q1 results, in line with our estimates… - Aena´s Q1 2024 results were in line with our estimates: revenue and EBITDA were +1.2% and +1.4%, ahead of our estimates, respectively, with the Spanish network +1.8% and +3.1% above (or € 18m and € 16m). The positive note of the results, in our view, came from the good Opex management at the Spanish network as, despite the continued upward trend already anticipated by the company, Opex grew below the traffic growth in ...

Benoit Valleaux ... (+2)
  • Benoit Valleaux
  • Steven Gould

CaixaBank : Opérationnel & capital au beau fixe au T1 2024

>Opinion Surperformance confortée – OC porté à 6.4 € (vs 5.9 €) - Les chiffres T1 2024 de CABK viennent confirmer la tendance favorable à la fois sur le plan opérationnel validant voire améliorant les guidances (RoTE dorénavant attendu >16%) et bilanciel (CET1 FL >12%) en 2024. Cette robustesse, couplée à la diversification adéquate du business model, conforte le titre parmi nos top picks au sein du secteur dans le contexte actuel incertain/challenging (macro, taux…)....

Jeremy Garnier
  • Jeremy Garnier

Orège : Résultats 2023 dégradés – 2024 sera encore une année de transi...

>CA de 1.2 M€ en retrait de 64% / ROC de -7.8 M€ - Orège a publié ce mardi ses résultats 2023 qui ressortent en dessous de notre attente. Pour un CA de 1.2 M€ en retrait de 64%, le ROC ressort à -7.8 M€ et le RNpg à -10.2 M€. Au 31 décembre 2023 la dette nette du groupe s’élève à 45.2 M€ (dette de 45.8 M€ dont 45 M€ liés aux avances en compte courant d’actionnaires et trésorerie de 0.6 M€). Depuis fin 2023, une nouvelle avance de 1.6 M€ a été engagée avec Eren Industr...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch